Envoy Medical Statistics
Total Valuation
Envoy Medical has a market cap or net worth of $53.12 million. The enterprise value is $51.80 million.
Important Dates
The next estimated earnings date is Thursday, April 30, 2026, after market close.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Envoy Medical has 76.88 million shares outstanding. The number of shares has increased by 23.78% in one year.
| Current Share Class | 76.88M |
| Shares Outstanding | 76.88M |
| Shares Change (YoY) | +23.78% |
| Shares Change (QoQ) | +30.29% |
| Owned by Insiders (%) | 37.17% |
| Owned by Institutions (%) | 2.71% |
| Float | 45.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 226.64 |
| Forward PS | 267.75 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 214.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.54
| Current Ratio | 0.54 |
| Quick Ratio | 0.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.89 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -137.34% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 735.02% |
| Weighted Average Cost of Capital (WACC) | 17.53% |
| Revenue Per Employee | $5,128 |
| Profits Per Employee | -$609,830 |
| Employee Count | 47 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 0.42 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.35% in the last 52 weeks. The beta is 2.05, so Envoy Medical's price volatility has been higher than the market average.
| Beta (5Y) | 2.05 |
| 52-Week Price Change | -50.35% |
| 50-Day Moving Average | 0.68 |
| 200-Day Moving Average | 0.96 |
| Relative Strength Index (RSI) | 49.10 |
| Average Volume (20 Days) | 435,113 |
Short Selling Information
The latest short interest is 804,479, so 1.05% of the outstanding shares have been sold short.
| Short Interest | 804,479 |
| Short Previous Month | 951,778 |
| Short % of Shares Out | 1.05% |
| Short % of Float | 1.76% |
| Short Ratio (days to cover) | 1.87 |
Income Statement
In the last 12 months, Envoy Medical had revenue of $241,000 and -$28.66 million in losses. Loss per share was -$1.23.
| Revenue | 241,000 |
| Gross Profit | -443,000 |
| Operating Income | -22.08M |
| Pretax Income | -23.76M |
| Net Income | -28.66M |
| EBITDA | -21.78M |
| EBIT | -22.08M |
| Loss Per Share | -$1.23 |
Full Income StatementBalance Sheet
The company has $3.74 million in cash and $919,000 in debt, with a net cash position of $2.82 million or $0.04 per share.
| Cash & Cash Equivalents | 3.74M |
| Total Debt | 919,000 |
| Net Cash | 2.82M |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | -11.77M |
| Book Value Per Share | -0.41 |
| Working Capital | -5.28M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$18.20 million and capital expenditures -$179,000, giving a free cash flow of -$18.38 million.
| Operating Cash Flow | -18.20M |
| Capital Expenditures | -179,000 |
| Depreciation & Amortization | 302,000 |
| Net Borrowing | 9.07M |
| Free Cash Flow | -18.38M |
| FCF Per Share | -$0.24 |
Full Cash Flow StatementMargins
| Gross Margin | -183.82% |
| Operating Margin | -9,161.83% |
| Pretax Margin | -9,857.26% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Envoy Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.78% |
| Shareholder Yield | -23.78% |
| Earnings Yield | -52.48% |
| FCF Yield | -33.65% |
Analyst Forecast
The average price target for Envoy Medical is $6.00, which is 768.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 768.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Envoy Medical has an Altman Z-Score of -59.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -59.67 |
| Piotroski F-Score | 3 |
